Ubs Group Ag Mereo Biopharma Group PLC Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.19 - $2.42 $3,347 - $6,807	2,813 New	2,813 $6,000
Q2 2023 Aug 11, 2023	SELL	$0.79 - $1.43 $73,996 - $133,942	-93,666 Reduced 97.41%	2,491 $3,000
Q1 2023 May 12, 2023	SELL	$0.71 - $1.22 $22,992 - $39,508	-32,384 Reduced 25.19%	96,157 $68,000
Q4 2022 Feb 08, 2023	SELL	$0.5 - $1.01 $19,482 - $39,353	-38,964 Reduced 23.26%	128,541 $96,000
Q3 2022 Nov 10, 2022	BUY	$0.82 - $1.73 $104,554 - $220,583	127,505 Added 318.76%	167,505 $144,000
Q2 2022 Aug 10, 2022	BUY	$0.33 - $1.69 $13,200 - $67,600	40,000 New	40,000 $45,000
Q1 2022 May 16, 2022	SELL	$1.04 - $1.7 $24,238 - $39,620	-23,306 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $20,169 - $34,594	13,357 Added 134.25%	23,306 $37,000
Q3 2021 Nov 15, 2021	BUY	$2.2 - $3.17 $19,841 - $28,590	9,019 Added 969.78%	9,949 $24,000
Q2 2021 Aug 13, 2021	SELL	$2.94 - $4.08 $12,315 - $17,091	-4,189 Reduced 81.83%	930 $3,000
Q1 2021 May 12, 2021	BUY	$2.6 - $4.43 $1,248 - $2,126	480 Added 10.35%	5,119 $17,000
Q4 2020 Feb 11, 2021	BUY	$1.95 - $3.6 $8,689 - $16,041	4,456 Added 2434.97%	4,639 $17,000
Q3 2020 Nov 12, 2020	SELL	$2.55 - $3.29 $1,994 - $2,572	-782 Reduced 81.04%	183 $0
Q2 2020 Jul 31, 2020	SELL	$1.0 - $3.4 $855 - $2,907	-855 Reduced 46.98%	965 $2,000
Q1 2020 May 01, 2020	SELL	$0.8 - $3.21 $4,119 - $16,528	-5,149 Reduced 73.88%	1,820 $2,000
Q4 2019 Feb 14, 2020	BUY	$1.1 - $3.7 $6,429 - $21,626	5,845 Added 520.02%	6,969 $23,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $4.14 $994 - $1,854	448 Added 66.27%	1,124 $3,000
Q2 2019 Aug 14, 2019	BUY	$2.52 - $6.5 $1,703 - $4,394	676 New	676 $1,000

Others Institutions Holding MREO

# of Institutions

Shares Held

107M

Call Options Held

209K

Put Options Held

479K

Rubric Capital Management LP New York, NY

15.3M
Shares

$46.1 Million
1.75% of portfolio
Janus Henderson Group PLC London, X0

12.3M
Shares

$37.2 Million
0.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.72M
Shares

$29.2 Million
0.07% of portfolio
Rock Springs Capital Management LP Baltimore, MD

9.53M
Shares

$28.7 Million
1.33% of portfolio
Mangrove Partners New York, NY

8.73M
Shares

$26.3 Million
4.66% of portfolio

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $376M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account